Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNPEP antisense RNA 1 (DNPEP-AS1) is a human long non-coding RNA gene located on chromosome 2 (region 2q35, chr2:219,388,496-219,403,633, hg38 build), transcribed as an antisense RNA relative to the DNPEP (Aspartyl aminopeptidase) gene. This locus produces an RNA molecule but does not encode a protein. Its specific biological function, regulatory roles, or involvement in disease processes are currently not characterized or supported by available functional studies.\n\nKey clarifications:\n- DNPEP-AS1 should not be confused with the DNPEP gene, which encodes the aspartyl aminopeptidase enzyme, a metalloenzyme involved in protein metabolism. DNPEP (the enzyme) is a valid protein target; DNPEP-AS1, the lncRNA, is not.\n- Some databases (GeneCards, Ensembl, BioGPS) confirm the status of DNPEP-AS1 as a non-coding RNA and not a protein or “canonical” drug target.\n- There is no evidence that DNPEP-AS1 is studied as a biomarker, disease gene, or a relevant node in therapeutic development.\n\nSummary:\nDNPEP-AS1 is an uncharacterized long non-coding antisense RNA gene without evidence of being a protein, therapeutic target, or disease biomarker. There are no drugs, disease associations, or functional data supporting it as a therapeutic node. This entry appears in gene naming databases but lacks other characterization, and should not be listed as a typical “receptor,” “enzyme,” or “target.”
None. No drugs target this RNA, so there are no mechanisms of drug action described for DNPEP-AS1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNPEP antisense RNA 1 (DNPEP-AS1).